544339

New Filing detected. See link for details.

New Filing detected. See link for details.

New Filing detected. See link for details.

- Q1 FY27 Consolidated Revenue ₹74.7 Cr vs ₹65.6 Cr (▲13.9% YoY) - EBITDA ₹14.4 Cr vs ~₹11.94 Cr (▲20.6% YoY) - PAT ₹10.3 Cr vs ~₹8.32 Cr (▲23.8% YoY) - EBITDA Margin 19.2% vs ~18% (▲120bps YoY) - Achieved strong segmental growth in Dental lab business (▲23.5% YoY), International business (▲37.4% YoY), Aligner solutions (▲28.6% YoY), and Paediatric dental business (▲54.4% YoY). - Executed Letter of Intent to acquire land in Palghar, Maharashtra, for a new owned facility to enhance operational efficiency and scalability. - Appointed a new CEO for the USA business to strengthen leadership and market-focused strategy. - Maintains FY27 guidance of 15-20% revenue growth and 18-20% EBITDA margin, with a long-term goal to grow beyond the industry CAGR. - Plans to deploy 800-1,000 scanners in the current financial year and continue investments in AI-led automation initiatives and branding efforts.

- Audio recording of Laxmi Dental Limited's Q1FY27 Earnings Conference Call is now available for access. - The call was held on Wednesday, August 12, 2026, at 11:00 A.M. (IST). - The recording has been uploaded to the company's website.

- Q1 FY27 Consolidated Revenue ₹747.0 Mn vs ₹656.0 Mn (▲13.9% YoY) - EBITDA ₹143.6 Mn vs ₹119.1 Mn (▲20.6% YoY) - PAT ₹103.2 Mn vs ₹83.3 Mn (▲23.8% YoY) - EBITDA Margin 19.2% vs 18.2% (▲100bps)

- Q1 FY27 Consolidated Revenue ₹747.0Mn vs ₹656.0Mn (▲13.9% YoY) - EBITDA ₹143.6Mn vs ₹119.1Mn (▲20.6% YoY) - PAT ₹103.2Mn vs ₹83.3Mn (▲23.8% YoY) - EBITDA Margin 19.2% vs 18.2% (▲100bps)

- Q1 FY27 Consolidated Revenue ₹72.99 Cr vs ₹64.32 Cr (▲13.48% YoY) - EBITDA ₹16.66 Cr vs ₹13.63 Cr (▲22.24% YoY) - PAT ₹9.55 Cr vs ₹7.31 Cr (▲30.64% YoY) - EBITDA Margin 22.83% vs 21.19% (▲164bps) - Approved the acquisition of land at Palghar, Maharashtra, for ₹62.10 Crores for business expansion by constructing a factory. - Approved the allotment of 59,360 equity shares to eligible employees under the Laxmi Dental Stock Option Scheme 2024.

- Q1 FY27 Consolidated Revenue ₹7.47Cr vs ₹6.56Cr (▲13.87% YoY) - EBITDA ₹1.44Cr vs ₹1.19Cr (▲20.62% YoY) - PAT ₹1.03Cr vs ₹0.83Cr (▲23.83% YoY) - EBITDA Margin 19.23% vs 18.15% (▲108 bps) - Board noted the execution of a Letter of Intent for the acquisition of land at Palghar for ₹6.21Cr to expand business operations by constructing a factory. - Approved the allotment of 59,360 Equity Shares to eligible employees under the ESOP 2024 scheme.

- Q1 FY26 Consolidated Operating Revenue ₹74.70Cr vs ₹65.60Cr (▲13.87% YoY) - EBITDA ₹14.36Cr vs ₹11.91Cr (▲20.62% YoY) - PAT ₹9.55Cr vs ₹7.31Cr (▲30.64% YoY) - EBITDA Margin 19.23% vs 18.15% (▲108bps) - Board noted the execution of a Letter of Intent for land acquisition at Palghar for ₹62.10 Cr, intended for factory expansion. - Approved the allotment of 59,360 equity shares to employees under the ESOP 2024 scheme.

- Q1 FY27 Consolidated Operating Revenue ₹74.70Cr vs ₹65.60Cr (▲13.87% YoY) - EBITDA ₹16.66Cr vs ₹13.63Cr (▲22.24% YoY) - PAT ₹10.30Cr vs ₹8.39Cr (▲22.76% YoY) - EBITDA Margin 22.30% vs 20.78% (▲152bps) - Approved acquisition of land at Palghar, Maharashtra for ₹62.10 Cr for factory expansion. - Approved allotment of 59,360 equity shares under ESOP 2024, increasing paid-up capital. - Noted surrender of 1,636 Employee Stock Options by an employee.

- Concall Schedule - Concall Date: August 12, 2026 - Concall Time: 11:00 AM IST

- Board meeting on August 11, 2026, to approve Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. - Trading window remains closed until 48 hours after results declaration.

- Laxmi Dental Limited disbursed an unsecured loan of ₹25 Lakhs to its subsidiary, Signature Smiles Dental Clinic Private Limited. - The total outstanding loan amount to the subsidiary is ₹1.25 Crore as of the disclosure date. - This disbursement is in accordance with a loan agreement to grant an aggregate amount not exceeding ₹50 Lakhs in multiple tranches.

- Concall Schedule - Concall Date: July 03, 2026 - Concall Time: 11:30 AM

- Trading window for Laxmi Dental Limited will remain closed for all Designated Persons and their immediate relatives from July 01, 2026. - This closure is ahead of the declaration of un-audited financial results for the quarter ended June 30, 2026, and will reopen 48 hours after results declaration.

- Concall Schedule - Concall Date: June 23, 2026 - Concall Time: 4.15 PM

Management expressed confidence in continued strong performance, guiding for sustained revenue growth similar to FY'26's 16.2% over the next two to three years. They anticipate maintaining or improving EBITDA margins to 18-20% and PAT margins to 13-15% by FY27/28, driven by operational leverage, automation, and digital dentistry investments. The company remains debt-free and holds ₹99 Cr in cash and bank balances, with plans for strategic Capex deployment. Key growth drivers include enhanced digital penetration, international market expansion, and new offerings like the iScope 360 remote dental platform.

Laxmi Dental Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report noted compliance deviations including a 2-day delay in submitting integrated financial filings for the quarter ended March 31, 2025 (fine of INR 11,800 paid), a 37-day delay for the quarter ended September 30, 2025 (fine of INR 218,300 paid). Additionally, there was a one-day delay in disclosing the resignation of the Company Secretary (KMP) due to non-availability of signatory. Related party transactions without prior Audit Committee approval were subsequently ratified.